1. Home
  2. FET vs LTGO Comparison

FET vs LTGO Comparison

Compare FET & LTGO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Forum Energy Technologies Inc.

FET

Forum Energy Technologies Inc.

N/A

Current Price

$69.24

Market Cap

953.8M

Sector

Industrials

ML Signal

N/A

Logo Latigo Biotherapeutics Inc. Common Stock

LTGO

Latigo Biotherapeutics Inc. Common Stock

N/A

Current Price

$13.00

Market Cap

924.9M

Sector

N/A

ML Signal

N/A

Company Overview

Basic Information
Metric
FET
LTGO
Founded
2005
2018
Country
United States
United States
Employees
N/A
N/A
Industry
Metal Fabrications
Sector
Industrials
Exchange
Nasdaq
Nasdaq
Market Cap
953.8M
924.9M
IPO Year
2007
2026

Fundamental Metrics

Financial Performance
Metric
FET
LTGO
Price
$69.24
$13.00
Analyst Decision
Strong Buy
Analyst Count
0
4
Target Price
N/A
★ $52.25
AVG Volume (30 Days)
138.6K
★ 242.3K
Earning Date
10-29-2026
11-05-2026
Dividend Yield
N/A
N/A
EPS Growth
★ 92.64
N/A
EPS
★ 2.38
N/A
Revenue
★ $791,474,000.00
N/A
Revenue This Year
$15.23
N/A
Revenue Next Year
$7.08
N/A
P/E Ratio
$30.27
★ N/A
Revenue Growth
N/A
★ N/A
52 Week Low
$29.77
$10.24
52 Week High
$91.99
$25.93

Technical Indicators

Market Signals
Indicator
FET
LTGO
Relative Strength Index (RSI) 37.63 41.33
Support Level $67.50 $11.00
Resistance Level $85.27 $15.95
Average True Range (ATR) 4.04 1.60
MACD -0.48 0.13
Stochastic Oscillator 11.82 48.34

Price Performance

Historical Comparison
FET
LTGO

About FET Forum Energy Technologies Inc.

Forum Energy Technologies Inc is a manufacturing company serving the oil, natural gas, industrial, and renewable energy industries. Its products include engineered capital equipment, as well as products that are consumed in the drilling, well construction, production, and transportation of oil and natural gas. The company operates in two reportable segments: Drilling and Completions, and Artificial Lift and Downhole. Maximum revenue is generated from the Drilling and Completions segment, which offers products used in the drilling process, and other products like hydraulic fracturing pumps, ROVs and trenchers, submarine rescue vehicles, etc. Geographically, the firm generates maximum revenue from the U.S., followed by Canada, Middle East, Europe and Africa, Asia-Pacific, and Latin America.

About LTGO Latigo Biotherapeutics Inc. Common Stock

Latigo Biotherapeutics Inc is a clinical-stage biotechnology company focused on developing non-opioid pain medicines designed to rapidly and effectively stop the transmission of pain without the risk of addiction. Its flagship product candidates, LTG-001 and LTG-321, are oral Nav1.8 inhibitors being developed for the treatment of acute pain. The company is also developing additional Nav1.8 inhibitor candidates using alternative formulations and delivery approaches.

Share on Social Networks: